Centennial Resource Development is one of many stocks the market is bullish on. Its expected double-digit top-line and bottom-line growth exceeds its peers, and its financially stable position lessens the chances of risk. Whether it be a well-known tech stock or a risky small-cap, I believe diversification towards growth can add value to your current holdings. Below I’ve compiled a list of stocks with a bright future ahead.
Centennial Resource Development, Inc. (NASDAQ:CDEV)
Centennial Resource Development, Inc., together with its subsidiary, Centennial Resource Production, LLC, operates as an independent oil and natural gas company in the United States. Established in 2015, and now led by CEO Mark Papa, the company provides employment to 119 people and has a market cap of USD $4.84B, putting it in the mid-cap stocks category.
CDEV is expected to deliver a buoyant earnings growth over the next couple of years of 31.31%, bolstered by an equally impressive revenue growth. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 11.10%. CDEV’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Interested to learn more about CDEV? Check out its fundamental factors here.
Meta Financial Group, Inc. (NASDAQ:CASH)
Meta Financial Group, Inc. operates as the holding company for MetaBank that offers various banking products and services to individuals, small businesses, financial institutions, and other businesses. Founded in 1954, and run by CEO J. Haahr, the company now has 827 employees and with the company’s market cap sitting at USD $1.06B, it falls under the small-cap stocks category.
A potential addition to your portfolio? Take a look at its other fundamentals here.
Savara Inc. (NASDAQ:SVRA)
Savara Inc. operates as an orphan lung disease company. The company now has 24 employees and with the market cap of USD $281.49M, it falls under the small-cap stocks category.
Considering SVRA as a potential investment? Check out its fundamental factors here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.